HIGH

Fagron Compounding Services Recalls Ophthalmic Solution Over Incorrect Formulation

Fagron Compounding Services recalled 2,980 syringes of a topical ophthalmic solution on November 20, 2025. The recall stems from an incorrect product formulation that could pose health risks. Consumers should stop using the product immediately and contact their healthcare provider for guidance.

Quick Facts at a Glance

Recall Date
November 20, 2025
Hazard Level
HIGH
Brand
Fagron Compounding Services
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Incorrect Product Formulation

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Fagron Compounding Services or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

The product is a topical ophthalmic solution used for eye care, including pupil dilation and inflammation control. Consumers typically buy this for procedures or conditions requiring eye examination or treatment.

Why This Is Dangerous

The product's incorrect formulation could lead to ineffective treatment or adverse reactions in patients. It is crucial to use properly formulated medications for ocular applications.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

The recall poses a high health risk, necessitating immediate cessation of use and consultation with healthcare professionals for any consumers who have used the product.

Practical Guidance

How to identify if yours is affected

  1. Locate the lot number on the syringe packaging.
  2. Check if it matches Lot#: C274-000047958.
  3. Verify the expiration date, which is December 19, 2025.

Where to find product info

You can find serial numbers and lot numbers on the packaging of the syringe, typically near the expiration date.

What timeline to expect

Expect a timeline of approximately 4-6 weeks for processing refunds or replacement.

If the manufacturer is unresponsive

  • Follow up with customer service via phone or email.
  • Document all communications for your records.
  • Contact the FDA if you do not receive a response.

How to prevent similar issues

  • Always check the NDC and lot numbers before using any medication.
  • Purchase medications from reputable sources to ensure quality and safety.
  • Be aware of recalls in the pharmaceutical industry.

Documentation advice

Keep all receipts, correspondence regarding the recall, and any medical advice received.

Product Details

The affected product is Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, packaged in 0.5mL single-use syringes. It is distributed by Fagron Sterile Services, located at 8710 E 34th St N, Wichita, KS 67226. The National Drug Code (NDC) is 71266-8240-01.

Key Facts

  • Recall date: November 20, 2025
  • Quantity recalled: 2,980 syringes
  • NDC: 71266-8240-01
  • Incorrect formulation poses high health risks
  • Consumers advised to stop use immediately

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeTopical Ophthalmic Solution
Sold At
Multiple Retailers

Product Details

Model Numbers
Lot#: C274-000047958
Exp. December 19
2025
Affected States
ALL
Report Date
December 17, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more